List of works by Heidi Weiss

A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia

scientific article

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

scientific article published on 27 July 2011

Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma

scientific article published in January 2006

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

scientific article

Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor.

scientific article published in May 2006

Case-matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States--possible role for human papillomavirus in survival disparities

scientific article

Characterization of Promoter Elements Regulating the Expression of the Human Neurotensin/Neuromedin N Gene ⬇️

scientific article published on October 28, 2010

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

scientific article published in December 2006

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

scientific article

Cotargeting the PI3K and RAS pathways for the treatment of neuroendocrine tumors

scientific article published on 17 January 2014

Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells

scientific article published on 30 August 2011

Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung

scientific article published on March 2002

Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients

scientific article published on 29 October 2008

Hedgehog signaling activation in the development of squamous cell carcinoma and adenocarcinoma of esophagus

scientific article published on 10 February 2012

Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy

scientific article

Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer

scientific article published on December 2014

Impact of post-radiation biopsies on development of fistulae in patients with cervical cancer

scientific article published on 11 February 2014

Maternal plasma viral load and neutralizing/enhancing antibodies in vertical transmission of HIV: a non-randomized prospective study

scientific article

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

scientific article published on 24 September 2006

NanoStringDiff: a novel statistical method for differential expression analysis based on NanoString nCounter data

scientific article

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer

scientific article

Nuclear accumulation of p53 is a potential marker for the development of squamous cell lung cancer in smokers

scientific article published on January 2003

Plasma TNF-α and Soluble TNF Receptor Levels after Doxorubicin with or without Co-Administration of Mesna-A Randomized, Cross-Over Clinical Study

scientific article published on 24 April 2015

Predicting the likelihood of an isocitrate dehydrogenase 1 or 2 mutation in diagnoses of infiltrative glioma

scientific article

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

scientific article published on December 2004

Regression of experimental medulloblastoma following transfer of HER2-specific T cells

scientific article published in June 2007

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function

scientific article

The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth

scientific article

Paulina is supported by:

About Paulina

Help